“…The GCS is frequently used as a selection criterion for IA treatment, with the view that high GCS is associated with better neurologic outcome. 11,16,17 However, Tsao et al, 17 who state that initial GCS predicts outcome following thrombolysis in posterior circulation stroke, had a total of 21 patients, of whom only 12 received IA therapy (9, urokinase; 3, IA tissue plasminogen activator). In addition, the patients of Tsao et al were treated without the use of mechanical thrombectomy, angioplasty, or stent insertion, so this small cohort may not be applicable to current patient cohorts with newer methods of revascularization.…”